CH₃CH₃
official

Bromantane: general

by ch3ch3 · 9h ago · 0 comments

Bromantane is a stimulant with calming effects, developed in the Soviet Union in the 1980s and made in Russia under the brand name Ladasten: “bromantane is manufactured in Russia (commercial name Ladasten)”.⁠[1] It belongs to the adamantane family, which also includes the prescription drugs amantadine and memantine. This page is a summary of what is known and what is not. It is not medical advice and it gives no amounts.

Where it comes from

Soviet researchers grouped bromantane with what they called actoprotectors, drugs meant to keep people working under heat and physical strain.⁠[1] A review of that research says “Bromantane also was employed in the Soviet and Russian armies to shorten recovery times after strong physical exertion”.⁠[1] It became known in the West as a doping case, and “Since 1997, anti-doping regulations have prohibited its use in sports”.⁠[1] It is still on the World Anti-Doping Agency's 2026 list of substances “PROHIBITED IN-COMPETITION”, under the name “Bromantan”.⁠[2] Anyone tested in sport should know that this applies however the product is labelled.

What the human studies found

Bromantane has been given to people in clinical studies, all of them in Russia and published in Russian. The largest was run “in 28 clinical centers of Russia”, with “The data on 728 patients with psychoautonomic syndrome”, all treated for fatigue-type (asthenic) disorders under medical care.⁠[3] It reported: “Adverse effects were observed only in 3% of patients, the therapy was discontinued in 0.8%”.⁠[3] A smaller placebo-controlled study used “a monotherapy with ladasten and placebo during 28 days and a final 1-week period of receiving placebo”, and its authors concluded: “The absence of "withdrawal syndrome" after the drug withdrawal reveals the lack of addictive potential in this drug”.⁠[4] The English-language review summarising this work says “bromantane administration in therapeutic doses is characterized by the almost full absence of side effects, including manifestations of withdrawal syndrome and hyperstimulation”.⁠[1]

Those findings deserve a careful reading. They come from patients with a diagnosis, taking a pharmaceutical product for about a month while doctors watched, in studies we could read only as abstracts.⁠[3][4] One week without withdrawal symptoms after a month of treatment is a short window.⁠[4] The studies do not cover months of daily use, higher amounts, combinations with other drugs, or powders of unknown purity bought outside a pharmacy. “Few side effects in a supervised trial” is not the same as “safe”, and this page does not treat it as such.

How it acts

In rat brains, Russian researchers found that “the dopaminergic effects are related to an increase in the dopamine release” in the first hours, and concluded that “the pharmacological activity of ladasten is related to activation of de novo synthesis of TH and DDC”, the enzymes that make dopamine.⁠[5] Dopamine is the brain chemical most stimulants act on.

Risks worth knowing

  • Heart and blood pressure. In animals, “Bromantan also weakly increases the pressor effects of adrenaline and noradrenaline”, the body's own blood-pressure hormones.⁠[6] Nobody has published a study of what that means for a person with heart disease or high blood pressure, or for someone combining it with other stimulants.
  • Other stimulant signs. In a rat toxicity study, “Bromantane induced mydriasis in all studied doses”: the pupils widened at every amount tested.⁠[7]
  • Mixed drug use. A US forensic laboratory first confirmed bromantane in a blood sample sent by a county medical examiner in Michigan, and “Bromantane was found alongside novel benzodiazepines (e.g., bromazolam) and traditional stimulants (e.g., methamphetamine)”.⁠[8] The laboratory reports that “Bromantane has been identified in one toxicology case to date at the CFSRE”.⁠[8] One case says nothing about what caused harm, but it shows bromantane turning up among other drugs.
  • Dependence. The Russian trials reported no withdrawal after a short course, as quoted above.⁠[4] We found no study of dependence after long or heavy use. A PubMed search on 2026-11-21 for bromantane with poisoning, overdose, case report, dependence or abuse found animal work and patient trials, and no case report of harm in a person.⁠[9] That is what our search found, not proof that harm has never happened.

What is not known

There is no established safe amount for use outside a prescription, and we found no published human data on how bromantane interacts with other drugs, including other stimulants, antidepressants and alcohol.⁠[9] What it does over months, or at more than the amounts used in the trials, is unknown. It is “not currently scheduled in the United States”, according to the forensic laboratory's 2024 report,⁠[8] which means nobody checks what is in a bottle sold as bromantane. The legal section covers its status in detail, and the experiences section collects what readers report.

References

  1. The Pharmacology of Actoprotectors: Practical Application for Improvement of Mental and Physical Performance (Oliynyk and Oh, Biomolecules & Therapeutics, 2012) — PubMed Central (US National Library of Medicine)
  2. World Anti-Doping Code International Standard: Prohibited List 2026 (Wayback Machine copy) — World Anti-Doping Agency
  3. Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten (Zhurnal Nevrologii i Psikhiatrii, 2010; in Russian, no authors listed) — PubMed (US National Library of Medicine)
  4. Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia: results of the comparative clinical study with placebo (Neznamov et al., Zhurnal Nevrologii i Psikhiatrii, 2009; in Russian) — PubMed (US National Library of Medicine)
  5. Ladasten induces the expression of genes regulating dopamine biosynthesis in various structures of rat brain (Vakhitova, Iamidanov and Seredinin, Eksperimental'naia i Klinicheskaia Farmakologiia, 2004; in Russian) — PubMed (US National Library of Medicine)
  6. The effect of bromantane on the cardiovascular and sympathetic-adrenal systems in animals (Morozov, Efimova and Kryzhanovskii, Eksperimental'naia i Klinicheskaia Farmakologiia, 2000; in Russian) — PubMed (US National Library of Medicine)
  7. Toxic effect of single treatment with bromantane on neurological status of experimental animals (Iezhitsa et al., Bulletin of Experimental Biology and Medicine, 2002) — PubMed (US National Library of Medicine)
  8. NPS Discovery New Drug Monograph: Bromantane (Walton et al., report date August 20, 2024) — Center for Forensic Science Research and Education (CFSRE)
  9. PubMed search for bromantane, Ladasten or bromantan together with poisoning, intoxication, overdose, case report, dependence or abuse (run 2026-11-21: 13 records, all animal work or patient trials; no case report of harm in a person) — PubMed (US National Library of Medicine)
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something